Literature DB >> 32093746

Functional Roles of Long Non-coding RNAs in Motor Neuron Development and Disease.

Kuan-Wei Chen1, Jun-An Chen2.   

Abstract

Long non-coding RNAs (lncRNAs) have gained increasing attention as they exhibit highly tissue- and cell-type specific expression patterns. LncRNAs are highly expressed in the central nervous system and their roles in the brain have been studied intensively in recent years, but their roles in the spinal motor neurons (MNs) are largely unexplored. Spinal MN development is controlled by precise expression of a gene regulatory network mediated spatiotemporally by transcription factors, representing an elegant paradigm for deciphering the roles of lncRNAs during development. Moreover, many MN-related neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA), are associated with RNA metabolism, yet the link between MN-related diseases and lncRNAs remains obscure. In this review, we summarize lncRNAs known to be involved in MN development and disease, and discuss their potential future therapeutic applications.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Long non-coding RNA; Motor neuron; Spinal muscular atrophy

Year:  2020        PMID: 32093746     DOI: 10.1186/s12929-020-00628-z

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  10 in total

1.  The expression discrepancy and characteristics of long non-coding RNAs in peripheral blood leukocytes from amyotrophic lateral sclerosis patients.

Authors:  Yujiao Yu; Dejiang Pang; Chunyu Li; Xiaojing Gu; Yongping Chen; Ruwei Ou; Qianqian Wei; Huifang Shang
Journal:  Mol Neurobiol       Date:  2022-04-02       Impact factor: 5.590

Review 2.  A putative role for lncRNAs in epigenetic regulation of memory.

Authors:  Ashleigh B Irwin; Rudhab Bahabry; Farah D Lubin
Journal:  Neurochem Int       Date:  2021-09-14       Impact factor: 3.921

Review 3.  The m6A epitranscriptome on neural development and degeneration.

Authors:  Ya-Ping Yen; Jun-An Chen
Journal:  J Biomed Sci       Date:  2021-05-27       Impact factor: 8.410

4.  Expression Profile of Long Non-Coding RNAs during Early Postnatal Development of Mouse Spinal Cord.

Authors:  Bert M Verheijen
Journal:  Noncoding RNA       Date:  2020-05-18

5.  Long noncoding RNA NEAT1 promotes cardiac fibrosis in heart failure through increased recruitment of EZH2 to the Smad7 promoter region.

Authors:  Zhuowang Ge; Chengye Yin; Yingze Li; Ding Tian; Yin Xiang; Qianhui Li; Yong Tang; Yachen Zhang
Journal:  J Transl Med       Date:  2022-01-03       Impact factor: 5.531

6.  A multifunctional locus controls motor neuron differentiation through short and long noncoding RNAs.

Authors:  Andrea Carvelli; Adriano Setti; Fabio Desideri; Pietro Laneve; Irene Bozzoni; Silvia Giulia Galfrè; Silvia Biscarini; Tiziana Santini; Alessio Colantoni; Giovanna Peruzzi; Matteo Jacopo Marzi; Davide Capauto; Silvia Di Angelantonio; Monica Ballarino; Francesco Nicassio
Journal:  EMBO J       Date:  2022-06-13       Impact factor: 14.012

Review 7.  Long Intergenic Noncoding RNAs Affect Biological Pathways Underlying Autoimmune and Neurodegenerative Disorders.

Authors:  Patrycja Plewka; Katarzyna Dorota Raczynska
Journal:  Mol Neurobiol       Date:  2022-07-07       Impact factor: 5.682

Review 8.  LncRNA, an Emerging Approach for Neurological Diseases Treatment by Regulating Microglia Polarization.

Authors:  Xiaoyu Gao; Zilong Cao; Haifeng Tan; Peiling Li; Wenen Su; Teng Wan; Weiming Guo
Journal:  Front Neurosci       Date:  2022-07-04       Impact factor: 5.152

Review 9.  Brain Long Noncoding RNAs: Multitask Regulators of Neuronal Differentiation and Function.

Authors:  Sarva Keihani; Verena Kluever; Eugenio F Fornasiero
Journal:  Molecules       Date:  2021-06-28       Impact factor: 4.411

Review 10.  Long non-coding RNAs in motor neuron development and disease.

Authors:  Vamshidhar R Vangoor; Andreia Gomes-Duarte; R Jeroen Pasterkamp
Journal:  J Neurochem       Date:  2020-10-10       Impact factor: 5.372

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.